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ABSTRACT
Context: The super-imposition of tuberculosis on the demands of pregnancy confers a grim prognosis.
Objectives: To determine the prevalence, pattern of presentation, management and outcome of tuberculosis 
among pregnant women in Ile-Ife during the first 10 years of the Millennium Development Goal-driven 
intervention.
Study Design: A retrospective analysis of 29 women managed for tuberculosis during pregnancy and the 
puerperium at the Obafemi Awolowo University Teaching Hospitals Complex (OAUTHC), Ile-Ife between 
2001 and 2010 was done using SPSS version 16.0. Prevalence was determined using the total deliveries over 
the same period. Social class was determined using the Olusanya et al classification and assessment for 
congenital tuberculosis was done with Cantwell's diagnostic criteria.
Results: There were 29 women with tuberculosis in pregnancy and puerperium, with 15,194 deliveries 
during the review period; giving a prevalence of 191 cases/100,000 deliveries. Cough and weight loss were 
the commonest complaints, and 53% of screened subjects were retroviral positive. Only 24% of these 
women were successfully treated using Directly Observed Treatment Short course; strike action and 
financial constraints being the hindering factors in 36% of them. The mean weight and EGA at birth were 
1.87±0.69kg and 35.1±4.0 weeks respectively. Maternal and fetal case-fatality rates were 16.6% and 31.6% 
respectively.
Conclusion: The high prevalence of tuberculosis in pregnancy in Ile-Ife is comparable to the national 
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figures. The associated high feto-maternal 
morbidity and mortality rates also contribute to the 
unhealthy statistics of the country. Prevention of 
HIV infection and consistent health service 
delivery are advocated to reduce this scourge. 
41
Trop J Obstet Gynaecol, 30 (2), August 2013
INTRODUCTION
Globally, an estimated 287,000 maternal deaths 
occurred in 2010. About 56% of these deaths 
occurred in Sub-Saharan Africa; with Nigeria 
alone contributing about 14% of the global 
burden. Tuberculosis (TB) is a significant 
contributor to this alarming rate of maternal 
mortality in Africa, being one of the three  
leading causes of death among women aged 
15-44 years. About 320,000 women were 
reported to have died from tuberculosis in 2010, 
and the disease was declared second only to 
HIV/AIDS as the leading cause of death due to a 
single infectious disease in 2011. Two TB-high 
burden countries; India (19%) and Nigeria 
(14%) contributed a third of the total global 
burden of maternal deaths recorded in 2010. 
This recognizable interplay between 
tuberculosis and maternal mortality easily 
justifies the renewed efforts currently being 
directed at tuberculosis prevention and control. 
The specific mention of TB among the diseases 
targeted by the United Nations Millennium 
Development Goals (UN MDG 6; target 6C) 
further brought the disease under the global 
spotlight. Gaps have however remained in the 
availability of vital information on the current 
impact of tuberculosis in Nigeria after more than 
10 years of MDG-driven interventions. We 
therefore set out to assess the prevalence and 
impact of tuberculosis on the course and 
outcome of pregnancies managed at the 
Obafemi Awolowo University Teaching 
Hospitals Complex, (OAUTHC) Ile-Ife, Nigeria 
during the first 10 years of the UN MDG 
programme. Our study also aimed to identify the 
significant factors affecting the management of 
these patients in our setting. 
S U B J E C T S ,  M A T E R I A L S  A N D  
METHODS
The study was conducted at the Obafemi 
Awolowo University Teaching Hospitals 
Complex, a tertiary health centre located in Ile-
Ife, a semi-urban town in Osun State, South-
west Nigeria. The major occupations of the 
inhabitants include farming, public service, 
craftsmanship and trading. The population is 
multiethnic, consisting mainly of Yoruba, Ibo 
and Hausa. 
The Health Information Service Department of 
the hospital was consulted and all the patients 
with tuberculosis in pregnancy and puerperium 
that were managed at the Obafemi Awolowo 
University Teaching Hospitals Complex, Ile-Ife 
between January 2001 and December 2010 were 
identified. Information related to the bio-
demography, clinical presentation, treatment, 
complications and feto-maternal outcome were 
obtained from the case notes using an 
appropriately designed study proforma. The 
records of yearly births during the period under 
review were obtained from the Hospital 
Statistics Department. Social class was 
determined using the Olusanya et al 
classification and assessment for congenital 
tuberculosis was done with the Cantwell's 
diagnostic criteria. The resulting data was 
analyzed using SPSS version 16.0.
RESULTS
Between January 2001 and December 2010, 29 
women were diagnosed with tuberculosis 
during pregnancy and the puerperium, and there 
were 15,194 deliveries in OAUTHC, Ile-Ife; 
giving a prevalence of 191 per 100,000 
deliveries. Some vital information were missing 
from the case records of four of the patients. 
Further analysis was therefore based on the 25 
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patients (94.8%) with adequate records.
The mean age of the patients was 27±6.5 years, 
with a range of 19 to 43 years. Their parity 
ranged from 0 to 8, with a median of 2. Only 20 
of these patients had sufficient information to 
be classified into social classes, and 17 (85%) of 
them belonged to social class 5. Twenty-one 
(84%) of these patients did not receive antenatal 
care in the pregnancy prior to the diagnosis of 
TB. The diagnosis was made in the first 
trimester in only three of the 17 patients that 
were diagnosed in the antenatal period, while 
seven patients each were diagnosed in the 
second and third trimesters. The remaining 
eight patients presented in the puerperium.
The commonest presenting complaints were 
cough and weight loss. Eight (53%) of the 15 
patients whose retroviral screening results were 
available tested positive. The presenting 
complaints were however similar between the 
HIV positive patients and their negative 
counterparts (table 1).
Twenty (80%) of the patients had pulmonary 
tuberculosis ,  whi le  extra-pulmonary 
involvement was present in five of them, 
including tuberculosis of the spine in four 
patients (16%), and tuberculous meningitis in 
one patient (4%). TB was correctly diagnosed at 
presentation in 18 (72%) of the patients based 
on clinical symptoms and signs while another 
five (20%) were initially misdiagnosed as 
pneumonia in pregnancy.
All the patients were admitted for investigation 
and treatment, with total duration of stay on 
admission ranging between four and 59 days. 
The mean duration of stay on admission was 
25±16.2 days. Anti-tuberculous therapy was 
commenced in 22 (88%) of the 25 patients; the 
commonest indication for instituting treatment 
being abnormal findings on roentgenography in 
13 (52%) of them. Ziehl Neelsen staining of 
sputum for acid fast bacilli was positive in only 
five (20%) of these patients while another four 
(16%) had a therapeutic trial. Directly Observed 
Therapy, Short Course (DOTS) was utilized in 
all 22 patients treated; rifampicin, isonizide, 
pyrazinamide and ethambutol being the 
commonest combination. The Respiratory Unit 
was involved in the co-management of 22 (88%) 
of the 25 patients; other units included 
Neurology (16%), Orthopaedics (16%), 
Haematology (12%), Cardiothoracic unit (16%) 
and Psychiatry (4%). None of the patients 
developed adverse drug reaction and none of the 
newborns exposed to anti-Koch's treatment in 
utero had any anomaly at birth. There was none 
of the neonates with features suggestive of 
congenital tuberculosis. 
Nineteen (76%) of these patients had clinically-
evident wasting at presentation. Other medical 
complications included anaemia, severe enough 
to warrant blood transfusion in nine women 
(36%), and pleural effusion that required closed 
thoracostomy tube drainage in four (16%) of 
them. Intra-uterine growth restriction was 
suspected in six (35%) of the 17 patients 
diagnosed antepartum. Twelve (75%) of the 16 
babies whose birth weights were known had low 
birth weight (with mean birth weight of 
1.87±0.69kg), while seven (43.7%) of these 
deliveries occurred prematurely. The mean 
gestational age at delivery was 35.1±4 weeks. A 
peculiar complication was the development of 
rd
3  degree uterovaginal prolapse in one of the 
patients in the postpartum period following 
several bouts of cough.
The Anti-tuberculous treatment schedule was 
completed in only six (24%) of the 25 patients, 
while more than a quarter of these patients (28%) 
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were lost to follow-up as shown on table 2.  
Three maternal deaths were recorded among the 
18 patients whose outcome as at time of 
discharge from the hospital was known, with a 
maternal case-fatality rate of 16.6%. Two of 
these three patients were diagnosed with TB in 
the third trimester, while the third was diagnosed 
in the puerperium. These three patients were 
unbooked and they all had extra-pulmonary 
involvement. Six of the 19 patients whose 
information on perinatal outcome were 
available had perinatal death; giving a perinatal 
case-fatality rate of 31.6%. There were 
concurrent maternal and perinatal losses in two 
patients.
DISCUSSION
The prevalence of 191 per 100,000 deliveries 
reported for tuberculosis in pregnancy and 
puerperium in this study is comparable to the 
199 per 100,000 reported for the general 
population of Nigeria in 2011 by WHO. This 
further confirms the assertion that the 
prevalence of tuberculosis in pregnancy is 
expected to be similar to that in the general 
population of that geographical region. The age 
range of 19-43 years in this study, and the 
predominance of the low socioeconomic class 
further lend credence to the ability of TB to 
perpetuate poverty by affecting the work force 
of the population. Though, the utilization of 
antenatal care services in Nigeria is low, the 16% 
utilization rate recorded among these patients is 
much less than the 45-58% reported in Nigeria 
in 2010.
The manifestations of TB in early pregnancy are 
often confused with early pregnancy symptoms, 
and the associated weight loss is often masked 
by the weight gain of pregnancy, thereby making 
the diagnosis of tuberculosis in pregnancy more 
challenging. This may probably explain why 
only three of the patients in our series presented 
in the first trimester. Majority of the patients in 
our series were however accurately diagnosed at 
presentation based on their florid clinical 
features. Extra-pulmonary TB was not as 
common as pulmonary TB in pregnancy in this 
study, contrary to a UK report where both had 
similar prevalence. 
Tuberculosis in pregnancy is not an indication 
for admission; the 100% admission rate in our 
patients was however dictated by the need for 
initial resuscitation, due to their poor clinical 
states at presentation. One out of every four 
patients with TB in this review was initially 
misdiagnosed as community acquired 
pneumonia. This highlights the need for a high 
index of suspicion at all times if the correct 
diagnosis of tuberculosis is not to be missed.
The unholy relationship between TB and 
HIV/AIDS was further demonstrated, as more 
than half of the patients whose retroviral status 
was known were positive. Though, this is not the 
practice in our centre, routine screening for TB 
has been advocated in Prevention of Maternal to 
Child Transmission of HIV (PMTCT) clinics 
because of the strong association that has been 
observed between these two diseases in other 
studies. 
As demonstrated in our review, with appropriate 
shielding of the fetus, roentgenography is cheap 
and invaluable in the management of these 
patients. The tendency to delay x-rays in 
pregnant women due to concerns about the 
possible hazards of ionizing radiation to the 
fetus can only delay diagnosis and institution of 
proper treatment in low resource settings. The 
20% smear positive rate reported in this study is 
44
Trop J Obstet Gynaecol, 30 (2), August 2013
lower than the 58% reported for the country in 
2010,  possibly due to the inability of pregnant 
women to generate adequate expulsive force to 
expectorate the tubercle bacilli. 
Interferon gamma assay is a promising 
investigation that is available in our centre for 
patients with TB, although its widespread use is 
presently limited by cost and the inability of the 
test to differentiate latent from active disease. 
The Xpert MTB/RIF is a WHO-endorsed rapid 
molecular test that accurately diagnoses TB and 
multi-drug resistant TB in 100 minute and is 
now available at a concessional price to about 
145 countries globally. This is expected to 
facilitate early diagnosis and accelerate 
patient's access to appropriate care.  
Globally, low birth weight affects some 20.6 
million babies annually, and its 96.5% 
predominance in developing countries is a 
reflection of the maternal health status in these 
countries.  The 75% case-related prevalence of 
low birth weight in our review is however about 
5 times the average global prevalence of 15.5%. 
Tuberculosis is associated with a high 
prevalence of growth restriction in utero and 
preterm delivery. 
Directly Observed Treatment using the Short 
Course strategy (DOTS) is the practice in our 
Centre, and the anti-tuberculous drugs are 
available at no cost to the patients. 
However, the 100% admission rate and the need 
for other supportive therapy including 
investigations, blood transfusion, antibiotics 
and intravenous infusions  for which patients 
usually have to make out of pocket payments 
probably explain the 28% rate of discharge 
against medical advice on financial grounds. 
Addi t iona l  e ffor t s  a t  making  the i r  
investigations and other supportive treatment 
available at no extra cost as we currently do for 
retroviral positive patients will definitely 
improve the outlook for these patients. 
Another 28% of our patients in this review were 
lost to follow-up after an initial stabilization and 
commencement of treatment, perhaps due to the 
paradoxical relationship between feeling of 
wellness and compliance with treatment in 
patients with chronic diseases. This act results in 
the development of multi-drug resistant TB and 
must be discouraged by ensuring adequate 
counselling on drug compliance, and a devoted 
community-health system partnership 
programme.
The  high maternal and perinatal case-fatality 
rates in our review underscores the devastating 
effect of tuberculosis on feto-maternal health in 
Nigeria, and the situation may not be too 
different in other developing countries where the 
disease is prevalent. As a further boost to  UN 
MDG 6C, the Global plan to stop TB initiative 
was launched in 2006, with the aim of reducing 
the prevalence and mortality of TB by 50% in 
2015 and eradicating TB by 2050. These targets 
are currently expected to be met by all regions 
globally except the African sub-region where 
Nigeria belongs. Eradication of TB will improve 
the chances of achieving the overall targets of the 
MDGs by contributing to improvement in 
maternal and child health, as well as reducing 
poverty. Morbidity and mortality among people 
living with HIV, 25% of which is directly 
attributable to TB will also reduce remarkably if 
this strategy is adopted.  
The current statistics of Nigeria demands 
additional strategy and improved co-ordination 
to achieve the desired goals on tuberculosis. 
While millions of patients have been treated and 
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cured of their disease since the introduction of 
DOTS, it is essential to state that chemotherapy 
is only a necessary, but insufficient approach to 
the eradication of tuberculosis. The other 
components of DOTS, including political will, 
at least 70% case detection rate through 
microscopy, adequate treatment of cases and 
impeccable record keeping must be emphasized 
as well. 
The establishment of a reliable community 
surveillance system will facilitate the detection 
of tuberculosis better than the current hospital-
based approach, and reduce the non-compliance 
rate among our patients, thereby reducing the 
incidence of multi-drug resistant TB. The 
collaborative community-based surveillance 
system established by the Federal Ministry of 
Health of Nigeria and the World Health 
Organization is a right step in this direction. We 
must also ensure meticulous civil data 
registration and disease notification, as these are 
complementary to a functional surveillance 
system in providing essential data for national 
planning.
HIV/AIDS has especially devastating effects in 
developing countries, and the nationwide 
fluctuations in the prevalence of TB are HIV-
driven. Investments in awareness programmes 
and other measure to prevent HIV infection will 
therefore ultimately reduce the prevalence of 
TB. Isoniazide preventive therapy (IPT) for 
tuberculosis is a WHO innovation that is aimed 
at preventing tuberculosis among HIV positive 
individuals by the administering Isoniazide at 
predetermined intervals; caution is however 
advised as  WHO is  yet  to  provide 
recommendations on the specific dose and time 
of administration during pregnancy.
Consistent health-service delivery is inevitable 
in tuberculosis eradication programmes. This 
should include accessible antenatal care 
services, and improved access to free 
investigations and treatment of HIV and TB. 
The Xpert MTB/RIF test is now available for 
routine use in 26 of the 145 countries that were 
granted concessional prices but Nigeria is yet to 
avail itself of this opportunity. Health-related 
human resources must also be optimized and the 
urban-rural dissociation in health service 
delivery in Nigeria must be appropriately 
addressed. 
th
Nigeria currently ranks 10  of the 22 TB-high 
burden countries, and  our annual maternal 
mortality reduction rate of 2.6%, which is barely 
half of the expected UN MDG 5 annual target of 
5.5%, is not satisfactory either. Eradication of 
poverty and improvement in the standards of 
living are advocated as worthy investments to 
reduce this scourge. While collaboration with 
international donor agencies and non-
governmental organizations is in line with UN 
MDG8, it can only be expected that the Nigerian 
Government will take up the responsibility of 
committing adequate human and financial 
resources to the health of its citizen, without 
having to rely on these support.
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Paraplegia 2 2 1 5
Haemoptysis 2 2 1 5
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